You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

PHENTERMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Phentermine Hydrochloride, and what generic alternatives are available?

Phentermine Hydrochloride is a drug marketed by Abc Holding, Able, Aurolife Pharma Llc, Barr, Camall, Chartwell Rx, Duramed Pharms Barr, Elite Labs, Elite Labs Inc, Invagen Pharms, Ivax Pharms, Kvk Tech, Lannett, Lannett Co Inc, Nuvo Pharm, Sandoz, Sun Pharm Industries, Teva, Tg United Inc, Upsher Smith Labs, Usl Pharma, Vitarine, Watson Labs, Zydus Pharms, Actavis Elizabeth, Kvk Tech Inc, Merro Pharm Usa, Novast Labs, Prinston Inc, Sandoz Inc, and Sun Pharm Inds Inc. and is included in eighty-seven NDAs.

The generic ingredient in PHENTERMINE HYDROCHLORIDE is phentermine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the phentermine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phentermine Hydrochloride

A generic version of PHENTERMINE HYDROCHLORIDE was approved as phentermine hydrochloride by ELITE LABS INC on May 30th, 1997.

  Try a Trial

Drug patent expirations by year for PHENTERMINE HYDROCHLORIDE
Recent Clinical Trials for PHENTERMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Health Science Center, HoustonPhase 4
Kaiser PermanentePhase 4
Biomedical Research Institute of New MexicoPhase 4

See all PHENTERMINE HYDROCHLORIDE clinical trials

Pharmacology for PHENTERMINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for PHENTERMINE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SUPRENZA Orally Disintegrating Tablets phentermine hydrochloride 37.5 mg 202088 1 2013-03-22
SUPRENZA Orally Disintegrating Tablets phentermine hydrochloride 15 mg and 30 mg 202088 1 2012-10-19

US Patents and Regulatory Information for PHENTERMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 083923-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Nuvo Pharm PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 205019-001 Dec 5, 2014 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ivax Pharms PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 086329-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Prinston Inc PHENTERMINE HYDROCHLORIDE phentermine hydrochloride TABLET;ORAL 040377-001 Jan 4, 2002 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Sandoz PHENTERMINE HYDROCHLORIDE phentermine hydrochloride CAPSULE;ORAL 088414-001 Oct 19, 1983 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.